Resources

Type of publications
Regions
Diseases

5192 results found

2025 ∙ Gloeck, N. R. Leong, T. D. Mthethwa, M. Iwu-Jaja, C. J. Katoto, Pdmc Wiysonge, C. S. Kredo, T.

Typhoid conjugate vaccines for preventing typhoid fever (enteric fever)

  • Children
  • Adolescents
  • Adults
  • Older adults
  • Typhoid
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
High
2025 ∙ Bardach, A. Brizuela, M. Berrueta, M. Ciapponi, A. Sambade, J. M. Ballivian, J. Ortega, V. Castellana, N. Comande, D. Parker, E. P. K. Kampmann, B. Stegelmann, K. Xiong, X. Stergachis, A. Munoz, F. M. Buekens, P. Mazzoni, A.

Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines

  • Pregnant women
  • Newborn
  • Children
  • Adolescents
  • Chikungunya
  • Safety
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Ojumu, A. Ibrahim, S. A. Seale, A. C. Fayehun, O. Gill, P.

Understanding factors influencing the implementation and uptake of less-established adult vaccination programmes: A meta-ethnography of COVID-19 vaccination in Nigeria

  • Africa
  • Nigeria
  • Adults
  • Older adults
  • Healthcare workers
  • COVID-19
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Satyam, S. M. El-Tanani, M. Bairy, L. K. Rehman, A. Srivastava, A. Kenneth, J. M. Prem, S. M.

Unraveling Cardiovascular Risks and Benefits of COVID-19 Vaccines: A Systematic Review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Scott, J. Abers, M. S. Marwah, H. K. McCann, N. C. Meyerowitz, E. A. Richterman, A. Fleming, D. F. Holmes, E. J. Moat, L. E. Redepenning, S. G. Smith, E. A. Stoddart, C. J. Sundaram, M. E. Ulrich, A. K. Alba, C. Anderson, C. J. Arpey, M. K. Borre, E. Ladines-Lim, J. Mehr, A. J. Rich, K. Watts, C. Basta, N. E. Jarolimova, J. Walensky, R. P. Dugdale, C. M.

Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026

  • All age groups
  • COVID-19
  • RSV (Respiratory syncytial virus)
  • Influenza
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Jafari, Z. Kolb, B. E. Aiken, S. Wilson, S.

Updates on Auditory Outcomes of COVID-19 and Vaccine Side Effects: An Umbrella Review

  • All age groups
  • Pregnant women
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Adusei-Mensah, F. Olubamwo, O. Olaleye, S. Akter, L. Balogun, O. S. Moshoeshoe, R. J. Awoniyi, L. Olawuni, A. Kauhanen, J.

Updating the impact of mRNA COVID-19 vaccine exposure during pregnancy on obstetric and neonatal outcomes

  • Pregnant women
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Adisu, M. A. Habtie, T. E. Kitaw, T. A. Zemariam, A. B.

Uptake of the Second Dose of the Measles Vaccine and Its Determinants Among Children Aged Less Than 5 Years: Systematic Review and Meta-Analysis

  • Africa
  • Ethiopia
  • Newborn
  • Children
  • Measles
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Chen, A. M. H. Draime, J. A. Engert, M. Pachucki, A. Zan, T. Craig, E. Gibson, N. Chukwuemeka, C. Tubb, S. M. Cole, J. W.

Utilization of Provider-Patient Communication Tools and Approaches to Facilitate Vaccine Confidence: A Systematic Review

  • All age groups
  • Parents/caregivers
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Pan, H. Yu, Y. Li, X. Wang, M. Wen, C. Dai, Q. Huang, L.

Vaccination and rheumatoid arthritis: an updated systematic review and meta-analysis of data from 25,949,597 participants

  • All age groups
  • Safety
Methodological quality (AMSTAR 2):
Low
Loading...